Managing COVID-19–associated Coagulopathy Webinar
This presentation will describe the factors contributing to coagulopathy in COVID-19 and discuss ongoing thromboprophylaxis clinical trials in the pre-hospitalization, hospitalization, and post-hospital discharge periods to reduce thrombotic risk in COVID-19.
- COVID-19 and Coagulopathy
- VTE
- Anticoagulant therapy
- Pathophysiology
- Thrombosis
- Coagulopathy and COVID-19
- covid-19 microthrombosis
- thromboinflammation covid-19
- thrombosis prophylaxis guidelines vte prophylaxis
- microclots with covid
- hypercoagulability of covid-19